All In MedTech

Device Trial Radar · NCT06109051

EndeavorOTC™ Prospective Product Registry

Last checked: Nov 20, 2026Latest source record: Jun 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

198

Actual

Start

Oct 3, 2023

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Akili Interactive Labs, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 31, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes

Summary

As written by the sponsor on the registry.

The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-world setting.

Conditions

  • ADHD

Interventions

  • EndeavorOTCDevice

    EndeavorOTC™ is an over-the-counter digital therapeutic designed to improve attention function, ADHD symptoms, and quality of life in users 18 years of age and older with primarily inattentive or combined-type ADHD, who have been identified as having a significant attentional impairment. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx, a prescription digital therapeutic indicated to improve attention function in children ages 8-12. EndeavorOTC is not intended to be a replacement for any form of ongoing treatment. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Computerized Adaptive Test, Mental Health (CAT-MH®)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12
  2. Conners' Adult ADHD Rating Scales-Self Report: Short Version (CAARS-S:S)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12
  3. Adult ADHD Quality of Life (AAQoL)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12

8 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Akili Interactive Labs, Inc.

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.